Classes
Publications
- Addition of Endothelin A-Receptor Blockade Spoils the Beneficial Effect of Combined Renin-Angiotensin and Soluble Epoxide Hydrolase Inhibition: Studies on the Course of Chronic Kidney Disease in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats2019 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease2018 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats2017 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Science
- The Dilemma of Dual Renin-Angiotensin System Blockade in Chronic Kidney Disease: Why Beneficial in Animal Experiments But Not in the Clinic?2017 | First Faculty of Medicine, Second Faculty of Medicine
- Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats2014 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Addition of ETA receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats2014 | First Faculty of Medicine, Third Faculty of Medicine
- SHARP study:Simvastatin+ezetimib versus placebo in patient with chronic kidney disease. Commentary on:Lancet 377,2011,2181-2192 +AHJ 160,2010,785-7942011 | First Faculty of Medicine
- Clinical features, outcomes, and response to corticosteroid treatment of acute tubulointerstitial nephritis: a single centre retrospective cohort study in Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine
- Intenzivní snížení tlaku u pacientů s CKD a riziko nežádoucích výsledků2023 | First Faculty of Medicine
- Doporučení k léčbě vysokého krevního tlaku Evropské společnosti pro hypertenzi podporované Evropskou renální asociací (ERA) a Mezinárodní společností pro hypertenzi (ISH)2023 | First Faculty of Medicine
Loading network view...